Introduction
There is evidence to suggest that presentation, treatment and survival from cancers may be dependent upon geographical access to services. Previous work has suggested that those living at long distances from healthcare or in rural areas may present with more advanced disease and have poorer prognoses. 1 -4 Our own recent study of breast, colorectal, lung, ovarian and prostate cancer registrations in Northern England found that late-stage presentations in breast and colorectal cancer patients and poorer survival in prostate cancer patients were associated with longer car journeys to general practitioner (GP) surgeries. 5 Few studies have examined whether poor geographical accessibility to health services may be associated with an elevated risk of cancer not being diagnosed until postmortem. An exception is Campbell et al., 1 who studied death certificate only (DCO) cases registered in Scotland during the period 1991 -95. DCOs are cases where the only information on the cancer is available from the death certificate. They found that stomach, breast and colorectal patients living at greater straight-line distances from an urban cancer centre were significantly more likely to have their cancer diagnosed post-mortem than their more proximal counterparts. Although age, sex and settlement size of patients were controlled for, the measure of service accessibility used in that work was crude, being based on straight-line distances to cancer centres (major treatment hospitals).
In a study of cancer registrations in England and Wales during the 1990s, Coleman et al. 6 found that overall 10.4% of patient records contained only information from the death certificate. A proportion of these DCO cases will reflect inadequacies in the cancer registration system and the number of DCO cases has long been used to estimate the incompleteness of cancer registry records. 7 However, the number of DCO cases generated by a population has been shown to be associated with both patient and area characteristics, 8 and the premise behind the study by Campbell et al.
1
was that a proportion of these records may relate to individuals who did not seek or receive medical attention until their illness was very far advanced. This study assesses whether the likelihood of a patient being registered as a cancer diagnosed at death, a term we prefer to DCO for the reasons stated below, was associated with access to services for diagnosis and treatment among a large population in Northern England. It uses a more sophisticated methodology than previously adopted to estimate car travel times to primary care and to hospital, takes into account the availability of public and community transport, and tests for interactions between accessibility and material deprivation.
Methods
The study was located in north-east England, the area covered by the Northern and Yorkshire Cancer Registry. The regional population is around 6.7 million. The area is very diverse both geographically and demographically, encompassing large rural tracts of North Cumbria, Northumberland and North and East Yorkshire together with major conurbations such as Leeds/Bradford, Newcastle-upon-Tyne and Middlesbrough.
The Northern and Yorkshire Cancer Registry Information Service (NYCRIS) supplied records of 120 826 patients registered with breast, colorectal, lung, ovarian or prostate cancer from 1 January 1994 to 31 December 2002. Males with breast cancer, ductal carcinoma in situ breast cancers, mesothelioma lung tumours and patients with atypical pathology types were omitted from analysis, as were those not resident in England. NYCRIS supplied details of age at diagnosis, sex and hospital(s) of treatment.
In our analysis, the outcome of interest was whether or not diagnosis was made at death, which we identified from records where the date of diagnosis matched the date of death. Our definition primarily encompasses records for patients where the only information regarding the cancer was written on the death certificate, or where cancer diagnosis was made at post-mortem. There will also be a small number of cases where diagnosis was made during surgery during which the patient died. It is the first group which are classified as 'DCO' in the cancer registry records. Our consequent inclusion of post-mortem diagnoses, which usually include histological diagnosis, means we do not use the term 'DCO' but rather we adopt 'cancers diagnosed at death'.
Each patient record was supplemented by additional information derived from their home postcode. Car travel times from each patient's address to their nearest National Health Service (state) hospital and their nearest GP (family physician) were estimated in a geographical information system, using estimates of average travel speeds over the road network. In order to compare our results with the findings of Campbell et al., 1 we also calculated the straightline distance to the nearest cancer centre. Patients' residences were classified according to whether they were within walking distance (800 m) of an hourly weekday bus service and whether there was a local community transport scheme available to take those without their own transport to see a health practitioner. Car travel times to the nearest railway station were also computed.
A socio-economic deprivation measure was calculated for each postcode based on the index of multiple deprivation (IMD 2004) scores. 9 The IMD 2004 is a composite measure of deprivation determined at the lower super output area (SOA) level, a census zone with a socio-economically homogeneous population of a minimum size of 1000 individuals. As the original index already includes a measure of access to services, each of the subdomains of the IMD was obtained separately, and deprivation scores were recalculated without the inclusion of the 'geographical barriers' subdomain. Postcodes were also classified with a dichotomous indicator of whether they fell within a rural or urban electoral ward (administrative area) according to the Countryside Agency classification of wards. 10 Further detail of data assembly, including how the confidentiality of individual records was safeguarded, is described in more detail elsewhere. 5 Statistical analyses were undertaken using SPSS for Windows version 16. Conditional logistic regression (backward stepwise likelihood ratio) models were fitted, with diagnosis at death status (yes/no) being the response variable. So that any trend associated with the measure was apparent, travel time to hospital was modelled as a categorical variable, with categories defined using quartiles. As there is evidence from elsewhere that area deprivation can act to compound any health disadvantages associated with poor access to healthcare, 11 interactions between deprivation and the accessibility measures were examined by fitting interaction terms between quartiles of deprivation and accessibility. Table 1 shows that diagnosis at death cases constituted, at most, 5.5% of all patients registered with each cancer. For all sites, the proportion of these cases were less than that reported in a study of socio-economic inequalities in cancer survival in England and Wales by Coleman et al., 6 but similar to that seen by Campbell et al. 7 in Scotland, possibly reflecting the high standard of certification data among our study population. Nevertheless, it is noteworthy that a substantial proportion of the cases also had at least one hospital attendance noted in their record, this figure being highest for colorectal patients (45%).
Results
There were some variations between sites, but the boundaries between the travel time quartiles were very 3, 5 min (the median) and 9 min for the nearest GP surgery. Estimated travel times quartiles to the nearest hospital were divided at 8, 12 min (the median) and 17 min. Table 2 details the observed associations with odds of being a diagnosis at death case from the logistic regression models. Age at diagnosis was significantly associated with increased odds of being a case for all tumour sites, with each additional year of age adding between 2% (lung) and 14% (breast) to the risk. Male gender was a significant risk for lung but not colorectal patients. Colorectal and ovary patients living in more deprived areas exhibited an elevated risk, whereas the risk was reduced for breast cancers. For colorectal cancers, patients with tumours in the colon, caecum or appendix were twice as likely to be diagnosed at death compared with those with tumours of the rectum or rectosigmoid junction. Lung cancer patients with either small cell or non-small cell tumours, a group that would comprise many clinically diagnosed patients who do not survive to biopsy or pathological examination, were significantly less likely to be diagnosed at death compared with other pathologies.
For all sites except breast, the highest odds of being a diagnosis at death case occurred among those living in the least accessible quartile of travel time for hospital, although Replacing the travel time to hospital and GP variables with alternative access measures, and continuing to control for age, sex, deprivation and pathology where appropriate, did not identify strongly consistent associations with the alternative measures of service accessibility and rurality (Table 3 ). It was found that the odds of a post-mortem diagnosis increased with distance to the nearest cancer centre, but only for colorectal and prostate cancers was this association strong enough to be statistically significant. Breast and prostate cancer patients living close to a frequent bus service were significantly less likely to be diagnosed at death, whereas there was an elevated risk for colorectal and prostate cancer patients living in rural wards.
Discussion
Main findings of the study
In this investigation, we did not find any evidence that the odds of death before diagnosis for cancer were associated with access to primary (GP) care. However, there was some evidence of an effect of access to tertiary care, with the highest odds being observed in the least accessible quartiles for colorectal and ovarian tumours. There was also a strong relationship with area deprivation where the odds of a record being associated with cancer diagnosis at death increased with increasing disadvantage, and there was evidence of an interaction between hospital accessibility and deprivation for colorectal cancer, whereby the highest odds were observed among those living in areas that were both the most deprived and the least accessible to hospital services.
What is already known on this topic
We know that presentation, treatment and survival from cancers may be dependent upon geographical access to services. Campbell et al.
1 used DCO cases registered in Scotland during the period 1991 -95 as a proxy for the diagnosis of cancer at death, finding that stomach, breast and colorectal patients with poorer access to an urban cancer centre were significantly more likely to be a DCO record. They suggested that this may reflect a problem of gaining access to care among more distant populations.
What this study adds
Like Campbell et al., 1 we also found that colorectal patients living at greater straight-line distance from an urban cancer centre were significantly more likely to have their cancer diagnosed post-mortem and we also found a significant association for prostate cancers. Yet, among patients in our study area, we know that fewer than 30% of individuals visited a cancer centre for initial treatment and diagnosis. 5 We feel our measures of travel time to the nearest hospital were more appropriate measures of accessibility because this is where the initial diagnostic work is expected to take place, whereas the indicator used by Campbell more captures Secondary access variables controlling for age, male, deprivation, site in bowel or lung pathology. *P , 0.05, **P , 0.01.
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remoteness, as the cancer centres were located in the only large urban areas in their study population. Nevertheless, our findings generally support those of Campbell et al. 1 that worse access to tertiary care may be associated with an elevated disk of cancer being diagnosed post-mortem but they differ somewhat to the pattern found for survival and stage at diagnosis for the cancer patients in Northern England who were diagnosed before death. 5 Although no effects of travel time to hospital were uncovered in that work, those patients who had longer journeys to their GP tended to be diagnosed at a later stage (breast and colorectal sites) and survive for a shorter time ( prostate cancers). In the present analysis, it was access to hospital not GP services that was found to show associations. A tendency for late stage diagnosis and poorer survival to be associated with areas of high social deprivation was, however, matched by a similar association between DCO cases and deprivation here.
Given that the expected route by which cancer diagnosis is made is via referral to hospital from the patient's GP, it is perhaps surprising that access to tertiary but not primary care was in some cases associated with elevated odds of diagnosis at death. Reasons for this observation may include a perception from the patient's point of view that services for diagnosis and treatment provided at a remote location are too inaccessible to justify using them. It is noteworthy that many of the patients with cancers diagnosed at death are old, and it may be that for elderly, frail patients, possibly with multiple morbidities, travelling for definitive diagnosis would be onerous and possibly of little value. There is growing awareness that the presentation of symptoms of cancer is common in the population who do not have the disease, and the GP's task is to identify which patients warrant referral for investigations to identify malignancy. 12 One possible explanation for our findings is that the accessibility of the relevant facility influences the threshold of concern that triggers the decision by the GP and the patient to initiate referral. The educational level and assertiveness of the patient, which are associated with socio-economic status, will influence this, and lower levels of contact with the relevant services may also mean that the GP's perception of what may be achieved for a patient is lessened. The fact that some of our patients who were diagnosed at death had evidence of histological investigation, e.g. those categorized as having small cell or non-small cell lung cancer who will have therefore undergone diagnostic intervention in secondary care may be an indication of a decision not to proceed with active management, and access may have a bearing on this. Deprivation seems to universally detract from all steps in the process of patients seeking and receiving timely appropriate management for cancer, and it may be that geographical accessibility to hospital services acts in a similar manner.
Limitations of this study
Weaknesses include the fact that we had no information on patient ethnicity or individual circumstances, and we relied on an area-based measure of deprivation. Although the study sample size was large, the proportion of patients who were diagnosed at death were small, particularly for ovary, breast and prostate cancers. As an indicator of the quality of cancer services, this fact is encouraging. It is also likely that some of these cases were associated with administrative inadequacies in the recording of cancer cases rather than actual diagnosis of cancer around the time of death. 8 Our outcome of interest would also have included some cases where diagnosis was made during a surgical procedure during or shortly after which the patient died, although these numbers were small. Deprivation of the area of residence was used as a surrogate for individual measures of socio-economic disadvantage, which were not available. The ecological fallacy is a possible pitfall as we do not know that cancer patients living in deprived areas were themselves deprived, although the large size of our sample minimized the likely effect of this problem.
It is important to recognize that access to health services depends on a wider range of factors than those associated with transport and will encompass the local ratio of doctors to patients and the availability of appointments. 13 Furthermore, presentation with advanced disease does not always imply delay but can reflect the aggressive nature of some tumours. 14 We had no information on waiting times and other such barriers, and neither was information available regarding patient co-morbidity or tumour grade. These shortcomings are not unusual in studies of this type and are difficult to avoid.
